Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 207

1.

Colonoscopy Indication Algorithm Performance Across Diverse Health Care Systems in the PROSPR Consortium.

Burnett-Hartman AN, Kamineni A, Corley DA, Singal AG, Halm EA, Rutter CM, Chubak J, Lee JK, Doubeni CA, Inadomi JM, Doria-Rose VP, Zheng Y.

EGEMS (Wash DC). 2019 Aug 2;7(1):37. doi: 10.5334/egems.296.

PMID:
31531383
2.

Diabetes in relation to Barrett's esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett's and Esophageal Adenocarcinoma Consortium.

Petrick JL, Li N, Anderson LA, Bernstein L, Corley DA, El Serag HB, Hardikar S, Liao LM, Liu G, Murray LJ, Rubenstein JH, Schneider JL, Shaheen NJ, Thrift AP, van den Brandt PA, Vaughan TL, Whiteman DC, Wu AH, Zhao WK, Gammon MD, Cook MB.

Cancer. 2019 Sep 6. doi: 10.1002/cncr.32444. [Epub ahead of print]

PMID:
31490550
3.

Clinical Molecular Marker Testing Data Capture to Promote Precision Medicine Research Within the Cancer Research Network.

Burnett-Hartman AN, Udaltsova N, Kushi LH, Neslund-Dudas C, Rahm AK, Pawloski PA, Corley DA, Knerr S, Feigelson HS, Hunter JE, Tabano DC, Epstein MM, Honda SA, Ter-Minassian M, Lynch JA, Lu CY.

JCO Clin Cancer Inform. 2019 Sep;3:1-10. doi: 10.1200/CCI.19.00026.

4.

Effect of Sex, Age and Positivity Threshold on Fecal Immunochemical Test Accuracy: a Systematic Review and Meta-Analysis.

Selby K, Levine EH, Doan C, Gies A, Brenner H, Quesenberry C, Lee JK, Corley DA.

Gastroenterology. 2019 Aug 22. pii: S0016-5085(19)41243-2. doi: 10.1053/j.gastro.2019.08.023. [Epub ahead of print]

PMID:
31472152
5.

Safety and Complications of Long-Term Proton Pump Inhibitor Therapy: Getting Closer to the Truth.

Corley DA.

Gastroenterology. 2019 Sep;157(3):604-607. doi: 10.1053/j.gastro.2019.07.039. Epub 2019 Jul 30. No abstract available.

PMID:
31378636
6.

Evaluating screening participation, follow-up and outcomes for breast, cervical and colorectal cancer in the PROSPR consortium.

Barlow WE, Beaber EF, Geller BM, Kamineni A, Zheng Y, Haas JS, Chao CR, Rutter CM, Zauber AG, Sprague BL, Halm EA, Weaver DL, Chubak J, Doria-Rose VP, Kobrin S, Onega T, Quinn VP, Schapira MM, Tosteson ANA, Corley DA, Skinner CS, Schnall MD, Armstrong K, Wheeler CM, Silverberg MJ, Balasubramanian BA, Doubeni CA, McLerran D, Tiro JA.

J Natl Cancer Inst. 2019 Jul 11. pii: djz137. doi: 10.1093/jnci/djz137. [Epub ahead of print]

PMID:
31292633
7.

Colorectal Cancer Screening in People With and Without HIV in an Integrated Health Care Setting.

Lam JO, Hurley LB, Udaltsova N, Alexeeff SE, Klein DB, Corley DA, Silverberg MJ.

J Acquir Immune Defic Syndr. 2019 Jul 1;81(3):284-291. doi: 10.1097/QAI.0000000000002024.

PMID:
31194703
8.

Comparison of Universal Versus Age-Restricted Screening of Colorectal Tumors for Lynch Syndrome Using Mismatch Repair Immunohistochemistry: A Cohort Study.

Li D, Hoodfar E, Jiang SF, Udaltsova N, Pham NP, Jodesty Y, Armstrong MA, Hung YY, Baker RJ, Postlethwaite D, Ladabaum U, Levin TR, Corley DA, Bergoffen J.

Ann Intern Med. 2019 Jul 2;171(1):19-26. doi: 10.7326/M18-3316. Epub 2019 Jun 11.

PMID:
31181578
9.

Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection.

Selby K, Levin TR, Corley DA.

Ann Intern Med. 2019 May 21;170(10):736-737. doi: 10.7326/L19-0095. No abstract available.

PMID:
31108529
10.

Treatment patterns and survival differ between early-onset and late-onset colorectal cancer patients: the patient outcomes to advance learning network.

Burnett-Hartman AN, Powers JD, Chubak J, Corley DA, Ghai NR, McMullen CK, Pawloski PA, Sterrett AT, Feigelson HS.

Cancer Causes Control. 2019 Jul;30(7):747-755. doi: 10.1007/s10552-019-01181-3. Epub 2019 May 17.

PMID:
31102084
11.

Time to Follow-up After Colorectal Cancer Screening by Health Insurance Type.

Breen N, Skinner CS, Zheng Y, Inrig S, Corley DA, Beaber EF, Garcia M, Chubak J, Doubeni C, Quinn VP, Haas JS, Li CI, Wernli KJ, Klabunde CN; PROSPR consortium.

Am J Prev Med. 2019 May;56(5):e143-e152. doi: 10.1016/j.amepre.2019.01.005.

PMID:
31003603
12.

Collaborating on Data, Science, and Infrastructure: The 20-Year Journey of the Cancer Research Network.

Doria-Rose VP, Greenlee RT, Buist DSM, Miglioretti DL, Corley DA, Brown JS, Clancy HA, Tuzzio L, Moy LM, Hornbrook MC, Brown ML, Ritzwoller DP, Kushi LH, Greene SM.

EGEMS (Wash DC). 2019 Mar 29;7(1):7. doi: 10.5334/egems.273. Review.

13.

Will a Proton Pump Inhibitor and an Aspirin Keep the Doctor Away for Patients With Barrett's Esophagus?

Fitzgerald RC, Corley DA.

Gastroenterology. 2019 Apr;156(5):1228-1231. doi: 10.1053/j.gastro.2019.03.001. Epub 2019 Mar 5. No abstract available.

PMID:
30849313
14.

Strategies to Improve Follow-up After Positive Fecal Immunochemical Tests in a Community-Based Setting: A Mixed-Methods Study.

Selby K, Jensen CD, Zhao WK, Lee JK, Slam A, Schottinger JE, Bacchetti P, Levin TR, Corley DA.

Clin Transl Gastroenterol. 2019 Feb;10(2):e00010. doi: 10.14309/ctg.0000000000000010.

15.

No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study.

Dong J, Gharahkhani P, Chow WH, Gammon MD, Liu G, Caldas C, Wu AH, Ye W, Onstad L, Anderson LA, Bernstein L, Pharoah PD, Risch HA, Corley DA, Fitzgerald RC; Stomach and Esophageal Cancer Study Consortium, Iyer PG, Reid BJ, Lagergren J, Shaheen NJ, Vaughan TL, MacGregor S, Love S, Palles C, Tomlinson I, Gockel I, May A, Gerges C, Anders M, Böhmer AC, Becker J, Kreuser N, Thieme R, Noder T, Venerito M, Veits L, Schmidt T, Schmidt C, Izbicki JR, Hölscher AH, Lang H, Lorenz D, Schumacher B, Mayershofer R, Vashist Y, Ott K, Vieth M, Weismüller J, Nöthen MM, Moebus S, Knapp M, Peters WHM, Neuhaus H, Rösch T, Ell C, Jankowski J, Schumacher J, Neale RE, Whiteman DC, Thrift AP.

Clin Gastroenterol Hepatol. 2019 Feb 1. pii: S1542-3565(19)30088-6. doi: 10.1016/j.cgh.2019.01.041. [Epub ahead of print]

PMID:
30716477
16.

Validation of the Hepatocellular Carcinoma Early Detection Screening (HES) Algorithm in a Cohort of Veterans With Cirrhosis.

Tayob N, Christie I, Richardson P, Feng Z, White DL, Davila J, Corley DA, Kanwal F, El-Serag HB.

Clin Gastroenterol Hepatol. 2019 Aug;17(9):1886-1893.e5. doi: 10.1016/j.cgh.2018.12.005. Epub 2018 Dec 14.

PMID:
30557738
17.

Long-term Risk of Colorectal Cancer and Related Deaths After a Colonoscopy With Normal Findings.

Lee JK, Jensen CD, Levin TR, Zauber AG, Schottinger JE, Quinn VP, Udaltsova N, Zhao WK, Fireman BH, Quesenberry CP, Doubeni CA, Corley DA.

JAMA Intern Med. 2019 Feb 1;179(2):153-160. doi: 10.1001/jamainternmed.2018.5565.

PMID:
30556824
18.

Receipt of Colonoscopy Following Diagnosis of Advanced Adenomas: An Analysis within Integrated Healthcare Delivery Systems.

Chubak J, McLerran D, Zheng Y, Singal AG, Corley DA, Doria-Rose VP, Doubeni CA, Kamineni A, Haas JS, Halm EA, Skinner CS, Zauber AG, Wernli KJ, Beaber EF; PROSPR consortium.

Cancer Epidemiol Biomarkers Prev. 2019 Jan;28(1):91-98. doi: 10.1158/1055-9965.EPI-18-0452. Epub 2018 Nov 20.

PMID:
30459208
19.

Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort.

Kamineni A, Tiro JA, Beaber EF, Silverberg MJ, Wheeler CM, Chao CR, Chubak J, Skinner CS, Corley DA, Kim JJ, Balasubramanian BA, Paul Doria-Rose V; PROSPR consortium.

Int J Cancer. 2019 Mar 15;144(6):1460-1473. doi: 10.1002/ijc.31940. Epub 2018 Dec 20.

PMID:
30353911
20.

Gastroenterology's Improvements and New Features.

Corley DA, Peek RM Jr, Lowe C, Brounstein L, Landis E.

Gastroenterology. 2018 Nov;155(5):1290-1292. doi: 10.1053/j.gastro.2018.10.005. Epub 2018 Oct 6. No abstract available.

PMID:
30300612
21.

Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death.

Doubeni CA, Fedewa SA, Levin TR, Jensen CD, Saia C, Zebrowski AM, Quinn VP, Rendle KA, Zauber AG, Becerra-Culqui TA, Mehta SJ, Fletcher RH, Schottinger J, Corley DA.

Gastroenterology. 2019 Jan;156(1):63-74.e6. doi: 10.1053/j.gastro.2018.09.040. Epub 2018 Sep 27.

PMID:
30268788
22.

Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection: A Community-Based Cohort Study.

Selby K, Jensen CD, Lee JK, Doubeni CA, Schottinger JE, Zhao WK, Chubak J, Halm E, Ghai NR, Contreras R, Skinner C, Kamineni A, Levin TR, Corley DA.

Ann Intern Med. 2018 Oct 2;169(7):439-447. doi: 10.7326/M18-0244. Epub 2018 Sep 18.

23.

Colorectal Cancer Screening Participation Among Asian Americans Overall and Subgroups in an Integrated Health Care Setting with Organized Screening.

Ghai NR, Jensen CD, Corley DA, Doubeni CA, Schottinger JE, Zauber AG, Lee AT, Contreras R, Levin TR, Lee JK, Quinn VP.

Clin Transl Gastroenterol. 2018 Sep 21;9(9):186. doi: 10.1038/s41424-018-0051-2.

24.

When Should Guidelines Change? A Clarion Call for Evidence Regarding the Benefits and Risks of Screening for Colorectal Cancer at Earlier Ages.

Corley DA, Peek RM Jr.

Gastroenterology. 2018 Oct;155(4):947-949. doi: 10.1053/j.gastro.2018.08.040. Epub 2018 Sep 4. No abstract available.

25.

Index colonoscopy-related risk factors for postcolonoscopy colorectal cancers.

Tollivoro TA, Jensen CD, Marks AR, Zhao WK, Schottinger JE, Quinn VP, Ghai NR, Zauber AG, Doubeni CA, Levin TR, Fireman B, Quesenberry CP, Corley DA.

Gastrointest Endosc. 2019 Jan;89(1):168-176.e3. doi: 10.1016/j.gie.2018.08.023. Epub 2018 Aug 23.

PMID:
30144415
26.

Overdiagnosis in Colorectal Cancer Screening: Time to Acknowledge a Blind Spot.

Kalager M, Wieszczy P, Lansdorp-Vogelaar I, Corley DA, Bretthauer M, Kaminski MF.

Gastroenterology. 2018 Sep;155(3):592-595. doi: 10.1053/j.gastro.2018.07.037. Epub 2018 Aug 1. No abstract available.

PMID:
30076834
27.

Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population.

Levin TR, Corley DA, Jensen CD, Schottinger JE, Quinn VP, Zauber AG, Lee JK, Zhao WK, Udaltsova N, Ghai NR, Lee AT, Quesenberry CP, Fireman BH, Doubeni CA.

Gastroenterology. 2018 Nov;155(5):1383-1391.e5. doi: 10.1053/j.gastro.2018.07.017. Epub 2018 Jul 19.

PMID:
30031768
28.

Obesity and renal cell carcinoma risk by histologic subtype: A nested case-control study and meta-analysis.

Callahan CL, Hofmann JN, Corley DA, Zhao WK, Shuch B, Chow WH, Purdue MP.

Cancer Epidemiol. 2018 Oct;56:31-37. doi: 10.1016/j.canep.2018.07.002. Epub 2018 Jul 18.

PMID:
30029068
29.

World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer.

Rutter MD, Beintaris I, Valori R, Chiu HM, Corley DA, Cuatrecasas M, Dekker E, Forsberg A, Gore-Booth J, Haug U, Kaminski MF, Matsuda T, Meijer GA, Morris E, Plumb AA, Rabeneck L, Robertson DJ, Schoen RE, Singh H, Tinmouth J, Young GP, Sanduleanu S.

Gastroenterology. 2018 Sep;155(3):909-925.e3. doi: 10.1053/j.gastro.2018.05.038. Epub 2018 Jun 27.

30.

Health care improvement and survivorship priorities of colorectal cancer survivors: findings from the PORTAL colorectal cancer cohort survey.

McMullen C, Bulkley J, Corley DA, Madrid S, Davis AQ, Hesselbrock R, Kurtilla F, Anderson CK, Arterburn D, Somkin CP, Pawloski PA, Ghai NR, Feigelson HS.

Support Care Cancer. 2019 Jan;27(1):147-156. doi: 10.1007/s00520-018-4299-6. Epub 2018 Jun 12.

31.

Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.

Wang Z, Shaheen NJ, Whiteman DC, Anderson LA, Vaughan TL, Corley DA, El-Serag HB, Rubenstein JH, Thrift AP.

Am J Gastroenterol. 2018 Aug;113(8):1148-1155. doi: 10.1038/s41395-018-0070-3. Epub 2018 Jun 8.

PMID:
29880962
32.

Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium.

Doubeni CA, Gabler NB, Wheeler CM, McCarthy AM, Castle PE, Halm EA, Schnall MD, Skinner CS, Tosteson ANA, Weaver DL, Vachani A, Mehta SJ, Rendle KA, Fedewa SA, Corley DA, Armstrong K.

CA Cancer J Clin. 2018 May;68(3):199-216. doi: 10.3322/caac.21452. Epub 2018 Mar 30.

33.

Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.

Dong J, Levine DM, Buas MF, Zhang R, Onstad L, Fitzgerald RC; Stomach and Oesophageal Cancer Study (SOCS) Consortium, Corley DA, Shaheen NJ, Lagergren J, Hardie LJ, Reid BJ, Iyer PG, Risch HA, Caldas C, Caldas I, Pharoah PD, Liu G, Gammon MD, Chow WH, Bernstein L, Bird NC, Ye W, Wu AH, Anderson LA, MacGregor S, Whiteman DC, Vaughan TL, Thrift AP.

Clin Gastroenterol Hepatol. 2018 Oct;16(10):1598-1606.e4. doi: 10.1016/j.cgh.2018.03.007. Epub 2018 Mar 15.

34.

Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States.

Singal AG, Corley DA, Kamineni A, Garcia M, Zheng Y, Doria-Rose PV, Quinn VP, Jensen CD, Chubak J, Tiro J, Doubeni CA, Ghai NR, Skinner CS, Wernli K, Halm EA.

Am J Gastroenterol. 2018 May;113(5):746-754. doi: 10.1038/s41395-018-0023-x. Epub 2018 Feb 27.

35.

Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.

Dong J, Buas MF, Gharahkhani P, Kendall BJ, Onstad L, Zhao S, Anderson LA, Wu AH, Ye W, Bird NC, Bernstein L, Chow WH, Gammon MD, Liu G, Caldas C, Pharoah PD, Risch HA, Iyer PG, Reid BJ, Hardie LJ, Lagergren J, Shaheen NJ, Corley DA, Fitzgerald RC; Stomach and Oesophageal Cancer Study (SOCS) consortium, Whiteman DC, Vaughan TL, Thrift AP.

Gastroenterology. 2018 Apr;154(5):1273-1281.e3. doi: 10.1053/j.gastro.2017.12.003. Epub 2017 Dec 13.

36.

Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.

Rutter CM, Kim JJ, Meester RGS, Sprague BL, Burger EA, Zauber AG, Ergun MA, Campos NG, Doubeni CA, Trentham-Dietz A, Sy S, Alagoz O, Stout N, Lansdorp-Vogelaar I, Corley DA, Tosteson ANA.

Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):158-164. doi: 10.1158/1055-9965.EPI-17-0378. Epub 2017 Nov 17.

37.

The 75th Diamond Anniversary of Gastroenterology: 1943-2018.

Peek RM, Corley DA.

Gastroenterology. 2018 Jan;154(1):1-5. doi: 10.1053/j.gastro.2017.10.019. Epub 2017 Nov 9. No abstract available.

PMID:
29128318
38.

Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests: A Systematic Review.

Selby K, Baumgartner C, Levin TR, Doubeni CA, Zauber AG, Schottinger J, Jensen CD, Lee JK, Corley DA.

Ann Intern Med. 2017 Oct 17;167(8):565-575. doi: 10.7326/M17-1361. Epub 2017 Oct 10. Review.

39.

Accurate Identification of Colonoscopy Quality and Polyp Findings Using Natural Language Processing.

Lee JK, Jensen CD, Levin TR, Zauber AG, Doubeni CA, Zhao WK, Corley DA.

J Clin Gastroenterol. 2019 Jan;53(1):e25-e30. doi: 10.1097/MCG.0000000000000929.

PMID:
28906424
40.

Dietary sugar/starches intake and Barrett's esophagus: a pooled analysis.

Li N, Petrick JL, Steck SE, Bradshaw PT, McClain KM, Niehoff NM, Engel LS, Shaheen NJ, Corley DA, Vaughan TL, Gammon MD.

Eur J Epidemiol. 2017 Nov;32(11):1007-1017. doi: 10.1007/s10654-017-0301-8. Epub 2017 Sep 1.

41.

Diagnosis and predictors of sessile serrated adenoma after educational training in a large, community-based, integrated healthcare setting.

Li D, Woolfrey J, Jiang SF, Jensen CD, Zhao WK, Kakar S, Santamaria M, Rumore G, Armstrong MA, Postlethwaite D, Corley DA, Levin TR.

Gastrointest Endosc. 2018 Mar;87(3):755-765.e1. doi: 10.1016/j.gie.2017.08.012. Epub 2017 Aug 24.

PMID:
28843582
42.

Impact of adenoma detection on the benefit of faecal testing vs. colonoscopy for colorectal cancer.

Meester RGS, Doubeni CA, Zauber AG, van Ballegooijen M, Corley DA, Lansdorp-Vogelaar I.

Int J Cancer. 2017 Dec 1;141(11):2359-2367. doi: 10.1002/ijc.30933. Epub 2017 Aug 31.

43.

Time to Diagnostic Testing After a Positive Colorectal Cancer Screening Test.

Doubeni CA, Corley DA, Levin TR.

JAMA. 2017 Aug 1;318(5):483. doi: 10.1001/jama.2017.9312. No abstract available.

44.

The Reply.

Lo Re V 3rd, Carbonari DM, Lewis JD, Roy JA, Corley DA.

Am J Med. 2017 Aug;130(8):e369. doi: 10.1016/j.amjmed.2017.03.062. No abstract available.

PMID:
28734384
45.

Primary care visit use after positive fecal immunochemical test for colorectal cancer screening.

Hillyer GC, Jensen CD, Zhao WK, Neugut AI, Lebwohl B, Tiro JA, Kushi LH, Corley DA.

Cancer. 2017 Oct 1;123(19):3744-3753. doi: 10.1002/cncr.30809. Epub 2017 Jun 16.

46.

The Troublesome Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma.

Schneider JL, Corley DA.

Gastrointest Endosc Clin N Am. 2017 Jul;27(3):353-364. doi: 10.1016/j.giec.2017.03.002. Review.

PMID:
28577761
47.

Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis Status.

Gowda C, Newcomb CW, Liu Q, Carbonari DM, Lewis JD, Forde KA, Goldberg DS, Reddy KR, Roy JA, Marks AR, Schneider JL, Kostman JR, Tate JP, Lim JK, Justice AC, Goetz MB, Corley DA, Lo Re V.

Open Forum Infect Dis. 2017 Jan 28;4(2):ofx012. doi: 10.1093/ofid/ofx012. eCollection 2017 Spring.

48.

Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis.

Corley DA, Jensen CD, Quinn VP, Doubeni CA, Zauber AG, Lee JK, Schottinger JE, Marks AR, Zhao WK, Ghai NR, Lee AT, Contreras R, Quesenberry CP, Fireman BH, Levin TR.

JAMA. 2017 Apr 25;317(16):1631-1641. doi: 10.1001/jama.2017.3634.

49.

Colorectal Cancer Screening Initiation After Age 50 Years in an Organized Program.

Fedewa SA, Corley DA, Jensen CD, Zhao W, Goodman M, Jemal A, Ward KC, Levin TR, Doubeni CA.

Am J Prev Med. 2017 Sep;53(3):335-344. doi: 10.1016/j.amepre.2017.02.018. Epub 2017 Apr 17.

50.

Racial/ethnic differences in obesity and comorbidities between safety-net- and non safety-net integrated health systems.

Balasubramanian BA, Garcia MP, Corley DA, Doubeni CA, Haas JS, Kamineni A, Quinn VP, Wernli K, Zheng Y, Skinner CS.

Medicine (Baltimore). 2017 Mar;96(11):e6326. doi: 10.1097/MD.0000000000006326.

Supplemental Content

Loading ...
Support Center